IR-Med Inc.
IR-Med Inc. IRME Peers
See (IRME) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IRME | $0.12 | +14.29% | 8.64M | -4.00 | -$0.03 | N/A |
| SMMNY | $26.81 | -2.12% | 120.29B | 25.78 | $1.04 | +1.20% |
| SEMHF | $53.40 | -1.11% | 59.89B | 25.67 | $2.08 | +2.07% |
| RYLPF | $23.67 | -1.57% | 21.89B | 81.61 | $0.29 | +3.98% |
| SONVY | $67.59 | +2.60% | 20.14B | 31.44 | $2.15 | +1.41% |
| SONVF | $324.30 | +0.34% | 19.33B | 30.14 | $10.76 | +1.77% |
| SNNUF | $14.60 | +2.10% | 12.78B | 31.06 | $0.47 | +2.57% |
| CHEOY | $85.91 | -0.54% | 11.24B | 46.95 | $1.83 | +1.63% |
| CHEOF | $170.00 | +1.19% | 11.09B | 46.45 | $3.66 | +1.63% |
| WILYY | $19.25 | +3.38% | 8.43B | 19.44 | $0.99 | N/A |
Stock Comparison
IRME vs SMMNY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, SMMNY has a market cap of 120.29B. Regarding current trading prices, IRME is priced at $0.12, while SMMNY trades at $26.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas SMMNY's P/E ratio is 25.78. In terms of profitability, IRME's ROE is +11.77%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, IRME is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs SEMHF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, SEMHF has a market cap of 59.89B. Regarding current trading prices, IRME is priced at $0.12, while SEMHF trades at $53.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas SEMHF's P/E ratio is 25.67. In terms of profitability, IRME's ROE is +11.77%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, IRME is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs RYLPF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, RYLPF has a market cap of 21.89B. Regarding current trading prices, IRME is priced at $0.12, while RYLPF trades at $23.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas RYLPF's P/E ratio is 81.61. In terms of profitability, IRME's ROE is +11.77%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, IRME is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs SONVY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, SONVY has a market cap of 20.14B. Regarding current trading prices, IRME is priced at $0.12, while SONVY trades at $67.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas SONVY's P/E ratio is 31.44. In terms of profitability, IRME's ROE is +11.77%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, IRME is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs SONVF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, SONVF has a market cap of 19.33B. Regarding current trading prices, IRME is priced at $0.12, while SONVF trades at $324.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas SONVF's P/E ratio is 30.14. In terms of profitability, IRME's ROE is +11.77%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, IRME is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs SNNUF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, SNNUF has a market cap of 12.78B. Regarding current trading prices, IRME is priced at $0.12, while SNNUF trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas SNNUF's P/E ratio is 31.06. In terms of profitability, IRME's ROE is +11.77%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, IRME is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs CHEOY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, CHEOY has a market cap of 11.24B. Regarding current trading prices, IRME is priced at $0.12, while CHEOY trades at $85.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas CHEOY's P/E ratio is 46.95. In terms of profitability, IRME's ROE is +11.77%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, IRME is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs CHEOF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, CHEOF has a market cap of 11.09B. Regarding current trading prices, IRME is priced at $0.12, while CHEOF trades at $170.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas CHEOF's P/E ratio is 46.45. In terms of profitability, IRME's ROE is +11.77%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, IRME is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs WILYY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, WILYY has a market cap of 8.43B. Regarding current trading prices, IRME is priced at $0.12, while WILYY trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas WILYY's P/E ratio is 19.44. In terms of profitability, IRME's ROE is +11.77%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, IRME is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs WILLF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, WILLF has a market cap of 7.86B. Regarding current trading prices, IRME is priced at $0.12, while WILLF trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas WILLF's P/E ratio is 19.31. In terms of profitability, IRME's ROE is +11.77%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, IRME is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs GNGBY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, GNGBY has a market cap of 5.42B. Regarding current trading prices, IRME is priced at $0.12, while GNGBY trades at $19.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas GNGBY's P/E ratio is 35.09. In terms of profitability, IRME's ROE is +11.77%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, IRME is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs GNGBF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, IRME is priced at $0.12, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, IRME's ROE is +11.77%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, IRME is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs NHNKY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, NHNKY has a market cap of 4.22B. Regarding current trading prices, IRME is priced at $0.12, while NHNKY trades at $12.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas NHNKY's P/E ratio is 21.94. In terms of profitability, IRME's ROE is +11.77%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, IRME is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs AMBBY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, AMBBY has a market cap of 4.18B. Regarding current trading prices, IRME is priced at $0.12, while AMBBY trades at $15.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas AMBBY's P/E ratio is 75.05. In terms of profitability, IRME's ROE is +11.77%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, IRME is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs AMBFF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, AMBFF has a market cap of 4.02B. Regarding current trading prices, IRME is priced at $0.12, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas AMBFF's P/E ratio is 75.82. In terms of profitability, IRME's ROE is +11.77%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, IRME is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs NHNKF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, NHNKF has a market cap of 2.46B. Regarding current trading prices, IRME is priced at $0.12, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, IRME's ROE is +11.77%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, IRME is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs VTRLY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, IRME is priced at $0.12, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas VTRLY's P/E ratio is 44.30. In terms of profitability, IRME's ROE is +11.77%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, IRME is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs GGNDF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, GGNDF has a market cap of 2.09B. Regarding current trading prices, IRME is priced at $0.12, while GGNDF trades at $14.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas GGNDF's P/E ratio is 17.52. In terms of profitability, IRME's ROE is +11.77%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, IRME is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs STSEY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, IRME is priced at $0.12, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas STSEY's P/E ratio is 39.41. In terms of profitability, IRME's ROE is +11.77%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, IRME is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs GNNDY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, GNNDY has a market cap of 2.02B. Regarding current trading prices, IRME is priced at $0.12, while GNNDY trades at $41.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas GNNDY's P/E ratio is 16.74. In terms of profitability, IRME's ROE is +11.77%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, IRME is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs SSII Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, SSII has a market cap of 1.90B. Regarding current trading prices, IRME is priced at $0.12, while SSII trades at $9.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas SSII's P/E ratio is -89.45. In terms of profitability, IRME's ROE is +11.77%, compared to SSII's ROE of -1.33%. Regarding short-term risk, IRME is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs OSSFF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, IRME is priced at $0.12, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, IRME's ROE is +11.77%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, IRME is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs DWRKF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, IRME is priced at $0.12, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, IRME's ROE is +11.77%, compared to DWRKF's ROE of N/A. Regarding short-term risk, IRME is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs MCRPF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, IRME is priced at $0.12, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, IRME's ROE is +11.77%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, IRME is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs OSSUY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, IRME is priced at $0.12, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, IRME's ROE is +11.77%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, IRME is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs MEDGF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, IRME is priced at $0.12, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, IRME's ROE is +11.77%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, IRME is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs DRWKF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, DRWKF has a market cap of 1.18B. Regarding current trading prices, IRME is priced at $0.12, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas DRWKF's P/E ratio is 9.10. In terms of profitability, IRME's ROE is +11.77%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, IRME is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs DGWPF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, DGWPF has a market cap of 1.18B. Regarding current trading prices, IRME is priced at $0.12, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas DGWPF's P/E ratio is 8.70. In terms of profitability, IRME's ROE is +11.77%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, IRME is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs XVIPF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, IRME is priced at $0.12, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas XVIPF's P/E ratio is 74.77. In terms of profitability, IRME's ROE is +11.77%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, IRME is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs LFTSF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, IRME is priced at $0.12, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, IRME's ROE is +11.77%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, IRME is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs ELEAF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, IRME is priced at $0.12, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas ELEAF's P/E ratio is 12.22. In terms of profitability, IRME's ROE is +11.77%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, IRME is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs CALZF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, CALZF has a market cap of 829.01M. Regarding current trading prices, IRME is priced at $0.12, while CALZF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas CALZF's P/E ratio is 120.00. In terms of profitability, IRME's ROE is +11.77%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, IRME is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs MDRSF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, IRME is priced at $0.12, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, IRME's ROE is +11.77%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, IRME is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs AVMR Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, IRME is priced at $0.12, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas AVMR's P/E ratio is -18.34. In terms of profitability, IRME's ROE is +11.77%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, IRME is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs CLVSF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, IRME is priced at $0.12, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, IRME's ROE is +11.77%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, IRME is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs IOBCF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, IOBCF has a market cap of 373.52M. Regarding current trading prices, IRME is priced at $0.12, while IOBCF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas IOBCF's P/E ratio is 37.50. In terms of profitability, IRME's ROE is +11.77%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, IRME is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs HYBT Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, IRME is priced at $0.12, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas HYBT's P/E ratio is N/A. In terms of profitability, IRME's ROE is +11.77%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, IRME is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs EAPIF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, IRME is priced at $0.12, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas EAPIF's P/E ratio is -1.96. In terms of profitability, IRME's ROE is +11.77%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, IRME is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs SNWV Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, SNWV has a market cap of 276.43M. Regarding current trading prices, IRME is priced at $0.12, while SNWV trades at $32.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas SNWV's P/E ratio is -5.19. In terms of profitability, IRME's ROE is +11.77%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, IRME is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs CSSPF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, IRME is priced at $0.12, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, IRME's ROE is +11.77%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, IRME is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs CLLKF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, CLLKF has a market cap of 259.03M. Regarding current trading prices, IRME is priced at $0.12, while CLLKF trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas CLLKF's P/E ratio is -8.52. In terms of profitability, IRME's ROE is +11.77%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, IRME is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs CYBQY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, CYBQY has a market cap of 250.50M. Regarding current trading prices, IRME is priced at $0.12, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas CYBQY's P/E ratio is -40.67. In terms of profitability, IRME's ROE is +11.77%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, IRME is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs HTLZF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, IRME is priced at $0.12, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, IRME's ROE is +11.77%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, IRME is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs BCCOY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, BCCOY has a market cap of 221.04M. Regarding current trading prices, IRME is priced at $0.12, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, IRME's ROE is +11.77%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, IRME is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs IMPZY Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, IRME is priced at $0.12, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, IRME's ROE is +11.77%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, IRME is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs AVHHL Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, AVHHL has a market cap of 176.38M. Regarding current trading prices, IRME is priced at $0.12, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, IRME's ROE is +11.77%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, IRME is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs CYBQF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, IRME is priced at $0.12, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas CYBQF's P/E ratio is -43.33. In terms of profitability, IRME's ROE is +11.77%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, IRME is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs BRNHF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, IRME is priced at $0.12, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, IRME's ROE is +11.77%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, IRME is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs EKDHF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, EKDHF has a market cap of 161.81M. Regarding current trading prices, IRME is priced at $0.12, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, IRME's ROE is +11.77%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, IRME is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs JMDMF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, JMDMF has a market cap of 151.31M. Regarding current trading prices, IRME is priced at $0.12, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, IRME's ROE is +11.77%, compared to JMDMF's ROE of N/A. Regarding short-term risk, IRME is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs PXMBF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, PXMBF has a market cap of 150.49M. Regarding current trading prices, IRME is priced at $0.12, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, IRME's ROE is +11.77%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, IRME is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs BRSYF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, IRME is priced at $0.12, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, IRME's ROE is +11.77%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, IRME is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs AMEUF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, IRME is priced at $0.12, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, IRME's ROE is +11.77%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, IRME is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs VMTHF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, IRME is priced at $0.12, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, IRME's ROE is +11.77%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, IRME is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs FDMDF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, IRME is priced at $0.12, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, IRME's ROE is +11.77%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, IRME is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs RSHUF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, IRME is priced at $0.12, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, IRME's ROE is +11.77%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, IRME is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs CKMTF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, IRME is priced at $0.12, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, IRME's ROE is +11.77%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, IRME is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs SOMNF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, IRME is priced at $0.12, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, IRME's ROE is +11.77%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, IRME is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs DMTRF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, IRME is priced at $0.12, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, IRME's ROE is +11.77%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, IRME is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs IPDQF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, IPDQF has a market cap of 75.83M. Regarding current trading prices, IRME is priced at $0.12, while IPDQF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas IPDQF's P/E ratio is -3.74. In terms of profitability, IRME's ROE is +11.77%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, IRME is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs SNZZF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, IRME is priced at $0.12, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, IRME's ROE is +11.77%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, IRME is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs RDGL Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, RDGL has a market cap of 60.75M. Regarding current trading prices, IRME is priced at $0.12, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas RDGL's P/E ratio is -13.40. In terms of profitability, IRME's ROE is +11.77%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, IRME is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs BLOZF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, BLOZF has a market cap of 50.08M. Regarding current trading prices, IRME is priced at $0.12, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas BLOZF's P/E ratio is -21.74. In terms of profitability, IRME's ROE is +11.77%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, IRME is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs NVYTF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, IRME is priced at $0.12, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas NVYTF's P/E ratio is -0.78. In terms of profitability, IRME's ROE is +11.77%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, IRME is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs TLTFF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, TLTFF has a market cap of 30.35M. Regarding current trading prices, IRME is priced at $0.12, while TLTFF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas TLTFF's P/E ratio is -12.25. In terms of profitability, IRME's ROE is +11.77%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, IRME is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs ELXMF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, IRME is priced at $0.12, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, IRME's ROE is +11.77%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, IRME is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs PYNKF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, PYNKF has a market cap of 26.55M. Regarding current trading prices, IRME is priced at $0.12, while PYNKF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas PYNKF's P/E ratio is -1.58. In terms of profitability, IRME's ROE is +11.77%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, IRME is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs KBBTF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, IRME is priced at $0.12, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, IRME's ROE is +11.77%, compared to KBBTF's ROE of N/A. Regarding short-term risk, IRME is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs EMITF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, IRME is priced at $0.12, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas EMITF's P/E ratio is -14.29. In terms of profitability, IRME's ROE is +11.77%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, IRME is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs ASAPF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, ASAPF has a market cap of 18.06M. Regarding current trading prices, IRME is priced at $0.12, while ASAPF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas ASAPF's P/E ratio is -23.39. In terms of profitability, IRME's ROE is +11.77%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, IRME is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs POSC Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, POSC has a market cap of 17.85M. Regarding current trading prices, IRME is priced at $0.12, while POSC trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas POSC's P/E ratio is 0.32. In terms of profitability, IRME's ROE is +11.77%, compared to POSC's ROE of +9.25%. Regarding short-term risk, IRME is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs MDXHF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, MDXHF has a market cap of 16.37M. Regarding current trading prices, IRME is priced at $0.12, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, IRME's ROE is +11.77%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, IRME is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs RMSL Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, RMSL has a market cap of 15.66M. Regarding current trading prices, IRME is priced at $0.12, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas RMSL's P/E ratio is 1.02. In terms of profitability, IRME's ROE is +11.77%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, IRME is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs VPTDF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, VPTDF has a market cap of 15.33M. Regarding current trading prices, IRME is priced at $0.12, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas VPTDF's P/E ratio is -4.70. In terms of profitability, IRME's ROE is +11.77%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, IRME is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs TMDIF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, IRME is priced at $0.12, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, IRME's ROE is +11.77%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, IRME is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs DIZTF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, IRME is priced at $0.12, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, IRME's ROE is +11.77%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, IRME is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs PLLWF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, IRME is priced at $0.12, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, IRME's ROE is +11.77%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, IRME is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs IMEXF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, IMEXF has a market cap of 11.63M. Regarding current trading prices, IRME is priced at $0.12, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas IMEXF's P/E ratio is N/A. In terms of profitability, IRME's ROE is +11.77%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, IRME is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs NGMDF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, NGMDF has a market cap of 11.51M. Regarding current trading prices, IRME is priced at $0.12, while NGMDF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas NGMDF's P/E ratio is -5.50. In terms of profitability, IRME's ROE is +11.77%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, IRME is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs ATBPF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, IRME is priced at $0.12, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, IRME's ROE is +11.77%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, IRME is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs LXXGF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, IRME is priced at $0.12, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, IRME's ROE is +11.77%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, IRME is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs GTHP Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, GTHP has a market cap of 9.75M. Regarding current trading prices, IRME is priced at $0.12, while GTHP trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas GTHP's P/E ratio is -2.50. In terms of profitability, IRME's ROE is +11.77%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, IRME is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs MKEAF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, MKEAF has a market cap of 6.72M. Regarding current trading prices, IRME is priced at $0.12, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, IRME's ROE is +11.77%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, IRME is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs TBRIF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, TBRIF has a market cap of 6.32M. Regarding current trading prices, IRME is priced at $0.12, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas TBRIF's P/E ratio is -1.39. In terms of profitability, IRME's ROE is +11.77%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, IRME is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs DTXMF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, IRME is priced at $0.12, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, IRME's ROE is +11.77%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, IRME is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs QLIS Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, IRME is priced at $0.12, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas QLIS's P/E ratio is 2.22. In terms of profitability, IRME's ROE is +11.77%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, IRME is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs RHNMF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, IRME is priced at $0.12, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, IRME's ROE is +11.77%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, IRME is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs MICR Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, IRME is priced at $0.12, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas MICR's P/E ratio is -3.47. In terms of profitability, IRME's ROE is +11.77%, compared to MICR's ROE of -0.25%. Regarding short-term risk, IRME is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs ADMT Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, ADMT has a market cap of 4.66M. Regarding current trading prices, IRME is priced at $0.12, while ADMT trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas ADMT's P/E ratio is -6.90. In terms of profitability, IRME's ROE is +11.77%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, IRME is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs FZMD Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, FZMD has a market cap of 4.43M. Regarding current trading prices, IRME is priced at $0.12, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas FZMD's P/E ratio is 1.20. In terms of profitability, IRME's ROE is +11.77%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, IRME is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs NUMD Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, NUMD has a market cap of 4.18M. Regarding current trading prices, IRME is priced at $0.12, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas NUMD's P/E ratio is 5.00. In terms of profitability, IRME's ROE is +11.77%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, IRME is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs LBLTF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, IRME is priced at $0.12, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, IRME's ROE is +11.77%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, IRME is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs VYCO Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, VYCO has a market cap of 4.01M. Regarding current trading prices, IRME is priced at $0.12, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas VYCO's P/E ratio is -12.03. In terms of profitability, IRME's ROE is +11.77%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, IRME is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs ALRTF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, ALRTF has a market cap of 3.81M. Regarding current trading prices, IRME is priced at $0.12, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas ALRTF's P/E ratio is -0.20. In terms of profitability, IRME's ROE is +11.77%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, IRME is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for IRME.
IRME vs BIEL Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, BIEL has a market cap of 3.62M. Regarding current trading prices, IRME is priced at $0.12, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas BIEL's P/E ratio is N/A. In terms of profitability, IRME's ROE is +11.77%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, IRME is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs VANIW Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, IRME is priced at $0.12, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas VANIW's P/E ratio is N/A. In terms of profitability, IRME's ROE is +11.77%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, IRME is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs USAQ Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, USAQ has a market cap of 2.71M. Regarding current trading prices, IRME is priced at $0.12, while USAQ trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas USAQ's P/E ratio is -8.00. In terms of profitability, IRME's ROE is +11.77%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, IRME and USAQ have similar daily volatility (13.33).
IRME vs ESMC Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, ESMC has a market cap of 2.48M. Regarding current trading prices, IRME is priced at $0.12, while ESMC trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas ESMC's P/E ratio is 33.40. In terms of profitability, IRME's ROE is +11.77%, compared to ESMC's ROE of +0.47%. Regarding short-term risk, IRME is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.
IRME vs PMEDF Comparison
IRME plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IRME stands at 8.64M. In comparison, PMEDF has a market cap of 2.25M. Regarding current trading prices, IRME is priced at $0.12, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IRME currently has a P/E ratio of -4.00, whereas PMEDF's P/E ratio is -1.50. In terms of profitability, IRME's ROE is +11.77%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, IRME is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for IRME.